cell lines. LC-2 demonstrates that PROTAC-mediated degradation is a viable option for attenuating oncogenic KRAS levels and downstream signaling in cancer cells.
No takes yet. Share an insight, caveat, or question.
Bond et al. (2020) studied this question.